Marzena Olesińska

6.1k total citations
124 papers, 1.8k citations indexed

About

Marzena Olesińska is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Marzena Olesińska has authored 124 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Rheumatology, 47 papers in Immunology and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Marzena Olesińska's work include Systemic Lupus Erythematosus Research (54 papers), Systemic Sclerosis and Related Diseases (31 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Marzena Olesińska is often cited by papers focused on Systemic Lupus Erythematosus Research (54 papers), Systemic Sclerosis and Related Diseases (31 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Marzena Olesińska collaborates with scholars based in Poland, Czechia and United States. Marzena Olesińska's co-authors include Agnieszka Paradowska‐Gorycka, Anna Felis‐Giemza, Katarzyna Romanowska‐Próchnicka, Ewa Haładyj, Paweł P. Jagodzińśki, Margarita Lianeri, Mariusz Wudarski, Ewa Więsik–Szewczyk, Barbara Stypińska and Piotr Piotrowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Marzena Olesińska

118 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marzena Olesińska Poland 21 934 743 394 264 221 124 1.8k
José María Pego‐Reigosa Spain 22 959 1.0× 503 0.7× 319 0.8× 138 0.5× 165 0.7× 82 1.6k
François Chasset France 25 1.1k 1.1× 620 0.8× 199 0.5× 160 0.6× 289 1.3× 108 1.9k
Hans‐Jacob Haga Norway 14 1.1k 1.2× 678 0.9× 317 0.8× 200 0.8× 296 1.3× 29 1.7k
Mauro Galeazzi Italy 20 1.5k 1.6× 755 1.0× 269 0.7× 268 1.0× 286 1.3× 51 2.1k
Masao Nawata Japan 24 1.2k 1.3× 536 0.7× 255 0.6× 126 0.5× 294 1.3× 47 1.8k
Jennifer M. Grossman United States 15 874 0.9× 494 0.7× 190 0.5× 251 1.0× 147 0.7× 16 1.5k
Fleur Cohen‐Aubart France 30 1.1k 1.2× 524 0.7× 477 1.2× 385 1.5× 139 0.6× 117 3.1k
Akira Sagawa Japan 17 630 0.7× 539 0.7× 233 0.6× 216 0.8× 226 1.0× 75 1.8k
Marten Trendelenburg Switzerland 29 1.2k 1.3× 1.6k 2.1× 211 0.5× 204 0.8× 382 1.7× 129 2.5k
William Shergy United States 19 1.2k 1.3× 561 0.8× 252 0.6× 228 0.9× 274 1.2× 24 1.9k

Countries citing papers authored by Marzena Olesińska

Since Specialization
Citations

This map shows the geographic impact of Marzena Olesińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzena Olesińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzena Olesińska more than expected).

Fields of papers citing papers by Marzena Olesińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzena Olesińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzena Olesińska. The network helps show where Marzena Olesińska may publish in the future.

Co-authorship network of co-authors of Marzena Olesińska

This figure shows the co-authorship network connecting the top 25 collaborators of Marzena Olesińska. A scholar is included among the top collaborators of Marzena Olesińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzena Olesińska. Marzena Olesińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wajda, Anna, et al.. (2024). NADPH oxidase expression profile and PBMC immunophenotypic changes in anti-TNF-treated rheumatoid arthritis patients. Clinical Immunology. 271. 110414–110414. 1 indexed citations
4.
Olesińska, Marzena, et al.. (2024). Drug-Induced Myopathies: A Comprehensive Review and Update. Biomedicines. 12(5). 987–987. 9 indexed citations
5.
Romanowska‐Próchnicka, Katarzyna, et al.. (2024). Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results. Journal of Clinical Medicine. 13(7). 2025–2025. 3 indexed citations
6.
Denton, Christopher P., Otylia Kowal‐Bielecka, Marzena Olesińska, et al.. (2023). POS1278 SAFETY AND PHARMACOKINETICS OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) AND IGPRO10 (INTRAVENOUS IMMUNOGLOBULIN) IN ADULTS WITH SYSTEMIC SCLEROSIS (SSC) – RESULTS FROM A PHASE 2 TRIAL. Annals of the Rheumatic Diseases. 82. 985–985. 3 indexed citations
7.
Felis‐Giemza, Anna, et al.. (2023). Safety of esthetic procedures in rheumatic patients: single-center survey of patients. Rheumatology International. 44(2). 357–362. 1 indexed citations
9.
Szukiewicz, Dariusz, et al.. (2021). An Overview of Neonatal Lupus with Anti-Ro Characteristics. International Journal of Molecular Sciences. 22(17). 9281–9281. 12 indexed citations
10.
Romanowska‐Próchnicka, Katarzyna, Anna Felis‐Giemza, Marzena Olesińska, et al.. (2021). The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding. International Journal of Molecular Sciences. 22(6). 2922–2922. 85 indexed citations
11.
Olesińska, Marzena, et al.. (2021). Haptoglobin and Its Related Protein, Zonulin—What Is Their Role in Spondyloarthropathy?. Journal of Clinical Medicine. 10(5). 1131–1131. 6 indexed citations
12.
Sowińska, Anna, Barbara Stypińska, Anna Wajda, et al.. (2020). The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus. Biomolecules. 10(3). 494–494. 7 indexed citations
13.
Olesińska, Marzena, et al.. (2020). Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis–From Research to Clinical Practice. Cells. 9(5). 1127–1127. 72 indexed citations
14.
Sierakowska, Matylda, Marzena Olesińska, Marek Brzosko, et al.. (2019). Factors associated with quality of life in systemic sclerosis: a cross-sectional study. Quality of Life Research. 28(12). 3347–3354. 27 indexed citations
15.
Kuca‐Warnawin, Ewa, Anna Wajda, Piotr Głuszko, et al.. (2019). AB0094 DIFFERENTIATION OF ADIPOSE DERIVED MESENCHYMAL STEM CELLS OBTAINED FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ANKYLOSING SPONDYLITIS AND SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases. 78. 1509–1509.
17.
Felis‐Giemza, Anna, et al.. (2014). Treatment of rheumatic diseases and hepatitis B virus coinfection. Rheumatology International. 35(3). 385–392. 7 indexed citations
18.
Więsik–Szewczyk, Ewa, et al.. (2011). Cardiovascular risk assessment in patients with systemic lupus erythematosus: practical aspects. Reumatologia/Rheumatology. 49(6). 419–425. 1 indexed citations
20.
Więsik–Szewczyk, Ewa, J K Łacki, Wojciech Feleszko, & Marzena Olesińska. (2010). Target Therapies in Systemic Lupus Erythematosus: Current State of the Art. Mini-Reviews in Medicinal Chemistry. 10(10). 956–965. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026